Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Aldosterone synthesis and secretion 💬
1件: MC2R 💬 Cosyntropin 💬 Tetracosactide 5件: 78, 83, 113, 145, 222 💬 💬
2 Breast cancer 💬
2件: ESR1, ESR2 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬
3 cAMP signaling pathway 💬
1件: MC2R 💬 Cosyntropin 💬 Tetracosactide 5件: 78, 83, 113, 145, 222 💬 💬
4 Chemical carcinogenesis - receptor activation 💬
3件: AR, ESR1, ESR2 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬
5 Cortisol synthesis and secretion 💬
1件: MC2R 💬 Cosyntropin 💬 Tetracosactide 5件: 78, 83, 113, 145, 222 💬 💬
6 Cushing syndrome 💬
1件: MC2R 💬 Cosyntropin 💬 Tetracosactide 5件: 78, 83, 113, 145, 222 💬 💬
7 Endocrine and other factor-regulated calcium reabsorption 💬
1件: ESR1 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬
8 Endocrine resistance 💬
2件: ESR1, ESR2 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬
9 Estrogen signaling pathway 💬
2件: ESR1, ESR2 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬
10 GnRH secretion 💬
1件: ESR2 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬
11 Hematopoietic cell lineage 💬
1件: MS4A1 💬 Rituximab 💬 Rituximab 48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 💬
12 Neuroactive ligand-receptor interaction 💬
1件: MC2R 💬 Cosyntropin 💬 Tetracosactide 5件: 78, 83, 113, 145, 222 💬 💬
13 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Betamethasone 💬 Betamethasone 8件:  2 , 28, 46, 65, 83, 90, 96, 235 💬 💬
14 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Hydrocortisone 💬 Hydrocortisone 10件:  6 , 41, 46, 53, 75, 78, 81, 83, 97, 299 💬 💬
15 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Hydrocortisone cypionate 💬 Hydrocortisone cypionate 3件:  6 , 81, 83 💬 💬
16 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Hydrocortisone succinate 💬 Hydrocortisone succinate 3件:  6 , 81, 83 💬 💬
17 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Methylprednisolone 💬 Methylprednisolone 46件:  2 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 💬
18 Oocyte meiosis 💬
1件: AR 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬
19 Pathways in cancer 💬
3件: AR, ESR1, ESR2 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬
20 Prolactin signaling pathway 💬
2件: ESR1, ESR2 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬
21 Prostate cancer 💬
1件: AR 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬
22 Proteoglycans in cancer 💬
1件: ESR1 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬
23 Thyroid hormone signaling pathway 💬
1件: ESR1 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬